365 related articles for article (PubMed ID: 10630070)
21. Effectiveness and safety of a novel gel dressing in the management of neuropathic leg ulcers in diabetic patients: a prospective double-blind randomized trial.
Abbruzzese L; Rizzo L; Fanelli G; Tedeschi A; Scatena A; Goretti C; Macchiarini S; Piaggesi A
Int J Low Extrem Wounds; 2009 Sep; 8(3):134-40. PubMed ID: 19703948
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of topical pale sulfonated shale oil in the treatment of venous leg ulcers: a randomized, controlled, multicenter study.
Beckert S; Warnecke J; Zelenkova H; Kovnerystyy O; Stege H; Cholcha W; Königsrainer A; Coerper S
J Vasc Surg; 2006 Jan; 43(1):94-100. PubMed ID: 16414395
[TBL] [Abstract][Full Text] [Related]
23. Randomized, controlled study of innovative spray formulation containing ozonated oil and α-bisabolol in the topical treatment of chronic venous leg ulcers.
Solovăstru LG; Stîncanu A; De Ascentii A; Capparé G; Mattana P; Vâţă D
Adv Skin Wound Care; 2015 Sep; 28(9):406-9. PubMed ID: 26280699
[TBL] [Abstract][Full Text] [Related]
24. [Topical action of an anabolic steroid on the healing process of human torpid ulcers of various types and of most common clinical occurrence].
Giacomini F; Rizzi B; Terni E
Biol Lat; 1966; 19(2):139-56. PubMed ID: 5961895
[No Abstract] [Full Text] [Related]
25. Isosorbide dinitrate spray as therapeutic strategy for treatment of chronic venous ulcers.
Sánchez-Vázquez R; Briseño-Rodríguez G; Cardona-Muñoz EG; Gálvez-Gastélum FJ; Totsuka-Sutto SE; Garcia-Benavides L
Angiology; 2008; 59(1):64-71. PubMed ID: 18319224
[TBL] [Abstract][Full Text] [Related]
26. [Use of mesoglycan in venous pathology].
Scondotto G; Catena G; Aloisi D
Minerva Med; 1997 Dec; 88(12):537-41. PubMed ID: 9540785
[TBL] [Abstract][Full Text] [Related]
27. Factors associated with recurrence of venous leg ulcers: a survey and retrospective chart review.
Finlayson K; Edwards H; Courtney M
Int J Nurs Stud; 2009 Aug; 46(8):1071-8. PubMed ID: 19185862
[TBL] [Abstract][Full Text] [Related]
28. [Local proteolytic treatment of infected leg ulcers].
Klemp P; Staberg B; Ravnborg L
Ugeskr Laeger; 1986 Mar; 148(13):760-2. PubMed ID: 3518175
[No Abstract] [Full Text] [Related]
29. Predicting time to healing by anatomical assessment of venous pathology.
Szewczyk MT; Jawień A; Migdalski A; Piotrowicz R; Grzela T; Brazis P
Med Sci Monit; 2009 Feb; 15(2):CR74-81. PubMed ID: 19179971
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of two different intermittent pneumatic compression cycle settings in the healing of venous ulcers: a randomized trial.
Nikolovska S; Arsovski A; Damevska K; Gocev G; Pavlova L
Med Sci Monit; 2005 Jul; 11(7):CR337-43. PubMed ID: 15990691
[TBL] [Abstract][Full Text] [Related]
31. Micronized diosmin (Detralex) for vein-related trophic ulcers: European experience.
Savel'ev VS; Pokrovskiĭ AV; Sapelkin SV; Bogachev VIu; Bogdanets LI; Zolotukhin IA
Angiol Sosud Khir; 2006; 12(3):53-60. PubMed ID: 17641615
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of ulcers caused by chronic venous insufficiency of the lower limbs].
Guida V; Camardella G
Minerva Med; 1970 Feb; 61(15):686-8. PubMed ID: 5417560
[No Abstract] [Full Text] [Related]
33. [Use of a minor fibrinolytic drug (mesoglycan) in phlebitis].
Scondotto G; De Fabritiis A; Guastarobba A; Amato AC; Filippini M
Minerva Med; 1984 Jul; 75(28-29):1733-8. PubMed ID: 6236381
[TBL] [Abstract][Full Text] [Related]
34. Quality of live as measured by the CIVQ 20. Questionnaire following oral mesoglycan treatment of patients with chronic venous disease.
Allegra C; Antignani PL
Int Angiol; 2014 Oct; 33(5):407-18. PubMed ID: 24566500
[TBL] [Abstract][Full Text] [Related]
35. [Therapy of leg ulcers with disodium cromoglycate (DNCG)--case reports ].
Hübner K; Darlath W
Z Hautkr; 1982 Jul; 57(14):1037-43. PubMed ID: 6812300
[TBL] [Abstract][Full Text] [Related]
36. Treatment of venous leg ulcers with Dermagraft.
Omar AA; Mavor AI; Jones AM; Homer-Vanniasinkam S
Eur J Vasc Endovasc Surg; 2004 Jun; 27(6):666-72. PubMed ID: 15121121
[TBL] [Abstract][Full Text] [Related]
37. Some effects of a topical collagen-based matrix on the microcirculation and wound healing in patients with chronic venous leg ulcers: preliminary observations.
Wollina U; Schmidt WD; Krönert C; Nelskamp C; Scheibe A; Fassler D
Int J Low Extrem Wounds; 2005 Dec; 4(4):214-24. PubMed ID: 16286373
[TBL] [Abstract][Full Text] [Related]
38. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
[TBL] [Abstract][Full Text] [Related]
39. The effect of amelogenins (Xelma) on hard-to-heal venous leg ulcers.
Vowden P; Romanelli M; Peter R; Boström A; Josefsson A; Stege H
Wound Repair Regen; 2006; 14(3):240-6. PubMed ID: 16808801
[TBL] [Abstract][Full Text] [Related]
40. Frequency rhythmic electrical modulation system in the treatment of chronic painful leg ulcers.
Janković A; Binić I
Arch Dermatol Res; 2008 Aug; 300(7):377-83. PubMed ID: 18629524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
